Metacrine Inc Ordinary Shares (NASDAQ:MTCR)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - MTCR
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - MTCR
- Market Cap$117.580m
- SymbolNASDAQ:MTCR
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS59101E1038
Company Profile
Metacrine Inc is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases. Its program targets the farnesoid X receptor, or FXR, which is central to modulating liver and GI diseases. Its FXR product candidates include MET409 and MET642.
Latest MTCR news
Currently there for this company. Visit our news hub for other news .